UBS Group Cuts Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $21.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target decreased by UBS Group from $22.00 to $21.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group’s price objective suggests a potential upside of 4.63% from the stock’s previous close.

A number of other research analysts also recently issued reports on SBRA. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $24.00 to $19.00 in a research report on Monday, June 22nd. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Cantor Fitzgerald lifted their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Finally, Barclays started coverage on shares of Sabra Healthcare REIT in a research note on Tuesday. They set an “overweight” rating and a $21.00 target price for the company. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Sabra Healthcare REIT currently has an average rating of “Hold” and a consensus target price of $21.45.

Sabra Healthcare REIT Stock Up 0.1%

SBRA traded up $0.01 on Wednesday, hitting $20.07. 1,265,767 shares of the company were exchanged, compared to its average volume of 2,725,201. The firm has a 50-day moving average price of $19.70 and a two-hundred day moving average price of $19.68. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $21.28. The company has a market cap of $5.06 billion, a price-to-earnings ratio of 31.84, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter last year, the business posted $0.37 EPS. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Institutional Trading of Sabra Healthcare REIT

Several institutional investors have recently modified their holdings of SBRA. Principal Financial Group Inc. grew its position in shares of Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares during the last quarter. Bank of Montreal Can boosted its stake in Sabra Healthcare REIT by 8.2% in the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after acquiring an additional 211,686 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Sabra Healthcare REIT by 16.5% during the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after purchasing an additional 201,667 shares during the last quarter. UBS Group AG increased its position in shares of Sabra Healthcare REIT by 143.1% during the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock worth $27,657,000 after purchasing an additional 859,584 shares in the last quarter. Finally, Advisors Capital Management LLC increased its position in shares of Sabra Healthcare REIT by 3.2% during the fourth quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock worth $45,133,000 after purchasing an additional 73,281 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.